Display Settings:

Format

Send to:

Choose Destination
See comment in PubMed Commons below
Semin Hematol. 2011 Apr;48(2):117-23. doi: 10.1053/j.seminhematol.2011.01.004.

Diamond Blackfan anemia treatment: past, present, and future.

Author information

  • 1Brigham and Women's Hospital, Department of Medicine, Boston, MA, USA.

Abstract

Despite significant improvements in our understanding of the pathophysiology of Diamond Blackfan anemia (DBA), there have been few advances in therapy. The cornerstones of treatment remain corticosteroids, chronic red blood cell transfusions, and hematopoietic stem cell transplantation, each of which is fraught with complications. In this article, we will review the history of therapies that have been offered to patients with DBA, summarize the current standard of care, including management of side effects, and discuss novel therapeutics that are being developed in the context of the research into the roles of ribosomal haplo-insufficiency and p53 activation in Diamond Blackfan anemia.

Copyright © 2011 Elsevier Inc. All rights reserved.

PMID:
21435508
[PubMed - indexed for MEDLINE]
PMCID:
PMC3073777
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science Icon for PubMed Central
    Loading ...
    Write to the Help Desk